Severe COVID-19 infection: An institutional review and literature overview

被引:2
|
作者
Akpoviroro, Ogheneyoma [1 ]
Sauers, Nathan Kyle [2 ]
Uwandu, Queeneth [1 ]
Castagne, Myriam [3 ]
Akpoviroro, Oghenetejiro Princess [4 ]
Humayun, Sara [1 ]
Mirza, Wasique [1 ]
Woodard, Jameson [1 ]
机构
[1] Geisinger Wyoming Valley Med Ctr, Dept Internal Med, Wilkes Barre, PA 18711 USA
[2] Penn State Univ, Dept Engn, State Coll, PA USA
[3] Boston Univ, Clin & Translat Sci Inst, Boston, MA USA
[4] Mater Dei Hosp, Dept Med, Msida, Malta
来源
PLOS ONE | 2024年 / 19卷 / 08期
关键词
ANGIOTENSIN-CONVERTING ENZYME; INVASIVE MECHANICAL VENTILATION; CONGESTIVE-HEART-FAILURE; OBSTRUCTIVE SLEEP-APNEA; CLINICAL CHARACTERISTICS; HOSPITALIZED-PATIENTS; SARS CORONAVIRUS; UNITED-STATES; LIVER-INJURY; AZITHROMYCIN;
D O I
10.1371/journal.pone.0304960
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background Our study aimed to describe the group of severe COVID-19 patients at an institutional level, and determine factors associated with different outcomes. Methods A retrospective chart review of patients admitted with severe acute hypoxic respiratory failure due to COVID-19 infection. Based on outcomes, we categorized 3 groups of severe COVID-19: (1) Favorable outcome: progressive care unit admission and discharge (2) Intermediate outcome: ICU care (3) Poor outcome: in-hospital mortality. Results Eighty-nine patients met our inclusion criteria; 42.7% were female. The average age was 59.7 (standard deviation (SD):13.7). Most of the population were Caucasian (95.5%) and non-Hispanic (91.0%). Age, sex, race, and ethnicity were similar between outcome groups. Medicare and Medicaid patients accounted for 62.9%. The average BMI was 33.5 (SD:8.2). Moderate comorbidity was observed, with an average Charlson Comorbidity index (CCI) of 3.8 (SD:2.6). There were no differences in the average CCI between groups(p = 0.291). Many patients (67.4%) had hypertension, diabetes (42.7%) and chronic lung disease (32.6%). A statistical difference was found when chronic lung disease was evaluated; p = 0.002. The prevalence of chronic lung disease was 19.6%, 27.8%, and 40% in the favorable, intermediate, and poor outcome groups, respectively. Smoking history was associated with poor outcomes (p = 0.04). Only 7.9% were fully vaccinated. Almost half (46.1%) were intubated and mechanically ventilated. Patients spent an average of 12.1 days ventilated (SD:8.5), with an average of 6.0 days from admission to ventilation (SD:5.1). The intermediate group had a shorter average interval from admission to ventilator (77.2 hours, SD:67.6), than the poor group (212.8 hours, SD:126.8); (p = 0.001). The presence of bacterial pneumonia was greatest in the intermediate group (72.2%), compared to the favorable group (17.4%), and the poor group (56%); this was significant (p<0.0001). In-hospital mortality was seen in 28.1%. Conclusion Most patients were male, obese, had moderate-level comorbidity, a history of tobacco abuse, and government-funded insurance. Nearly 50% required mechanical ventilation, and about 28% died during hospitalization. Bacterial pneumonia was most prevalent in intubated groups. Patients who were intubated with a good outcome were intubated earlier during their hospital course, with an average difference of 135.6 hours. A history of cigarette smoking and chronic lung disease were associated with poor outcomes.
引用
收藏
页数:34
相关论文
共 50 条
  • [1] Severe COVID-19 infection: An institutional review and literature overview (vol 19, e0304960, 2024)
    Akpoviroro, O.
    Sauers, N. K.
    Uwandu, Q.
    Castagne, M.
    Akpoviroro, O. P.
    Humayun, S.
    PLOS ONE, 2024, 19 (09):
  • [2] Covid-19 and Fungal Infection: A literature review
    Darmadi, Darmadi
    Pakpahan, Cennikon
    Surja, Sem Samuel
    RAWAL MEDICAL JOURNAL, 2023, 48 (03): : 795 - 798
  • [3] An Overview of COVID-19 Infection
    Goldwire, Micheline A.
    US PHARMACIST, 2022, 47 (04) : 46 - 56
  • [4] Intravenous Immunoglobulin for Treatment of Severe Coronavirus Disease 19 (COVID-19) - A Literature Overview
    Rizvi, Syed
    Kreuwel, Huub
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2021, 147 (02) : AB67 - AB67
  • [5] Severe COVID-19 Infection during Pregnancy Requiring ECMO: Case Report and Review of the Literature
    Diago-Munoz, Diana
    Martinez-Varea, Alicia
    Perez-Sancho, Esther
    Diago-Almela, Vicente
    JOURNAL OF PERSONALIZED MEDICINE, 2023, 13 (02):
  • [6] Hand conditions as sequelae of infection with COVID-19: a literature review
    Koo, Kenneth Kin-Hoo
    Morris, James
    Ansari, Saif Akhter
    Younis, Fizan
    JOURNAL OF HAND SURGERY-EUROPEAN VOLUME, 2024, 49 (02) : 284 - 289
  • [7] Rhabdomyolysis secondary to COVID-19 infection and vaccination: a review of literature
    Karimi, Mehdi
    Faal Hamedanchi, Neda
    Ansari, Kazem
    Nahavandi, Reza
    Mazdak, Mahsa
    Javaherchian, Fateme
    Koochaki, Pooneh
    Asadi Anar, Mahsa
    Shirforoush Sattari, Mahsa
    Mohamaditabar, Mona
    FRONTIERS IN MEDICINE, 2024, 11
  • [8] The Interrelationship between HIV Infection and COVID-19: A Review of the Literature
    Wang, Yiyu
    Lai, Yu
    CURRENT HIV RESEARCH, 2024, 22 (01) : 6 - 15
  • [9] Literature Review of Hemadsorption Therapy in Severe COVID-19 Cases: a Narrative Review
    Koc, Suna
    Uysal, Harun
    CLINICAL LABORATORY, 2022, 68 (02) : 401 - 409
  • [10] Predictors for Severe COVID-19 Infection
    Bhargava, Ashish
    Fukushima, Elisa Akagi
    Levine, Miriam
    Zhao, Wei
    Tanveer, Farah
    Szpunar, Susanna M.
    Saravolatz, Louis
    CLINICAL INFECTIOUS DISEASES, 2020, 71 (08) : 1962 - 1968